Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion type Assertion NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_head.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion description "[The use of SAGE analysis allowed us to identify a significant number of genes implicated in different cellular pathways up- or down-regulated in the presence of ERBB2 over-expression, including genes not previously implicated in breast cancer that could be considered as potential candidate markers for prognosis and therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_provenance.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion evidence source_evidence_literature NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_provenance.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion SIO_000772 16685446 NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_provenance.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion wasDerivedFrom befree-2016 NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_provenance.
- NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_assertion wasGeneratedBy ECO_0000203 NP549010.RAm_tCvgh6R-YLafOJlDJR6g3IXP5q6JcB9rLATWmHN0A130_provenance.